R&D News | pharmaphorum

News

Rick Slayman, kidney xenotransplantation patient

First recipient of pig kidney transplant dies

The first person to receive a transplant of a kidney from a pig has died almost two months after the procedure, although the transplant itself does not seem to be involved

News

Maze gets new Pompe partner after FTC blocks Sanofi deal

Five months after Sanofi backed away from a proposed deal with Maze Therapeutics on a Pompe disease therapy after an antitrust challenge, Shionogi has snapped up the drug.

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

News

Bluejay hatches $182m funding egg for hepatitis drugs

Bluejay Therapeutics has completed a sizeable third-round financing, raising $182 million that will be used for clinical trials of its drug candidates for hepatitis.

News

AlphaFold 3 takes structure predictions well beyond proteins

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”,

News

Report warns economic instability has hit UK drug discovery

A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on

First recipient of pig kidney transplant dies

Maze gets new Pompe partner after FTC blocks Sanofi deal

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Bluejay hatches $182m funding egg for hepatitis drugs

AlphaFold 3 takes structure predictions well beyond proteins

Report warns economic instability has hit UK drug discovery

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks